District of Columbia Statutes

§ 48-803.03a — Dispensing of substitute drug products by pharmacists — notification of substitution.

District of Columbia § 48-803.03a
JurisdictionDistrict of Columbia
Title 48Foods and Drugs.
Ch. 8Prescription Drug Price Information.
Subch. IIISubstitution of Therapeutically Equivalent Drugs.

This text of District of Columbia § 48-803.03a (Dispensing of substitute drug products by pharmacists — notification of substitution.) is published on Counsel Stack Legal Research, covering District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
D.C. Code § 48-803.03a (2026).

Text

(a)An individual shall be notified of a drug substitution, including an interchangeable biological product, and provided the right to refuse the substitution prior to purchase of the substitute drug product.
(1)The Department of Health shall create and distribute to all pharmacies signs that state in block letters not less than one inch in height: “This pharmacy may substitute a less expensive drug product that is equivalent to the one prescribed by your health care practitioner unless you request otherwise.
(2)Each pharmacy shall display the sign in a prominent place that has a clear and unobstructed public view at or near the place where prescriptions are dispensed.

Free access — add to your briefcase to read the full text and ask questions with AI

Legislative History

Sept. 10, 1976, D.C. Law 1-81, title III, § 301; as added Mar. 11, 2010, D.C. Law 18-118, § 2(d), 57 DCR 901

Nearby Sections

15
View on official source ↗

Cite This Page — Counsel Stack

Bluebook (online)
District of Columbia § 48-803.03a, Counsel Stack Legal Research, https://law.counselstack.com/statute/dc/48-803.03a.